Published in Gene Therapy Weekly, February 21st, 2002
The strategy of using a combination of therapies attempts to overcome previous problems seen in gene therapies meant for treating brain tumors, for it addresses the need for antigen presentation as well as sufficient immune cell recruitment, according to Y. Iwadate and associates at Chiba University Graduate School of Medicine in Japan.
"We investigated the therapeutic potential of induced systemic immunity in peripheral tissues combined with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.